Androfill vs. PMMA Girth Enhancement: A Clinical Comparison

How Androfill (hyaluronic acid) and PMMA-based enhancement compare — mechanism, duration, cost over time, and when each makes clinical sense.

androfill-vs-pmma-girth-enhancement

Dr. Luis Casavantes | Dr. Palmira Morales

Avanti Derma, Tijuana, Mexico

Androfill is a marketed protocol for penile girth enhancement using hyaluronic acid (HA) filler. It is offered by clinics worldwide, primarily in the United Kingdom, the Philippines, and select US markets. Patients researching global options frequently encounter it. This article compares Androfill directly to the permanent PMMA-based approach that has anchored our practice for two decades.

What Androfill Is

Androfill is not a proprietary material. It is a clinical protocol built around HA — the same material class marketed elsewhere under names like Urofill or as generic HA girth enhancement (see our Urofill vs PMMA comparison). The specific HA product used varies by clinic and jurisdiction. What is consistent is the mechanism: cross-linked HA gel that adds volume by binding water in the subcutaneous plane.

The result is temporary. HA in penile tissue is metabolized over approximately 9–14 months, at which point re-treatment is required to maintain volume. The material is fully reversible with hyaluronidase at any point.

What PMMA Is

PMMA microspheres are non-degradable. Once placed and encapsulated by the patient's own collagen, the result is structurally permanent. There is no maintenance schedule and no metabolic clock. The material is not reversible. Our 10-year PMMA outcomes review covers the long-term behavior in detail.

Cost Over Time — the Underappreciated Calculation

A single Androfill session costs less than a single PMMA session. This is often the primary appeal. The comparison changes when you calculate cost over 10 years.

A patient who selects HA (Androfill) and maintains the result requires re-treatment approximately every 12–18 months. Over a decade, cumulative cost typically meets or exceeds the one-time cost of a PMMA plan. This is not an argument for PMMA — it is an argument for calculating the full economic picture before choosing.

Reversibility — a Real Feature, Not a Marketing Line

Androfill's reversibility is genuine and clinically valuable. A patient who is uncertain, who wants to experience the result before committing to permanence, or who anticipates changing preferences over time is well served by HA as a first step. This is the correct use case.

The mistake is treating reversibility as automatically preferable regardless of patient. A patient who has already lived with an HA result for two years and knows exactly what he wants is not helped by keeping the option to reverse it. He is helped by preserving the outcome.

When Androfill Makes Clinical Sense

  • First-time patients who have never had a filler in this anatomy.

  • Patients whose risk tolerance for permanence is low.

  • Patients who prefer a temporary result they can reassess annually.

  • Patients in jurisdictions where PMMA is not available and who are not willing to travel.

When PMMA Makes Clinical Sense

  • Patients who have already experienced an HA result and want to preserve it.

  • Patients who prefer stability without repeat procedures every 12–18 months.

  • Patients who have been thoroughly screened for both anatomical and psychological readiness.

  • Patients who value the cumulative cost math over decades.

Frequently Asked Questions

Is Androfill safer than PMMA?

Not inherently. Complications in both categories cluster around the same factors: provider experience and patient selection. The safety difference is reversibility — if something goes wrong with HA, hyaluronidase resolves it. PMMA correction is more complex, which is why patient selection is stricter.

Can I start with Androfill and later switch to PMMA?

Yes, and this is a common trajectory. Many patients begin with HA to experience the result, then progress to PMMA once they have decided on permanence. The HA typically resorbs before the PMMA session; if any residual remains, it can be dissolved.

Does Androfill produce as much girth as PMMA?

Per session, comparable — both produce 2.5–3.5 cm of mid-shaft circumference in a well-executed session. The difference is not per-session outcome; it is durability.

Why do prices vary so much between Androfill clinics globally?

Clinic-specific pricing, jurisdictional cost differences, HA product cost, and provider experience level. A patient comparing prices across jurisdictions should also compare provider volume in this specific procedure.

Is travel to Mexico for PMMA worth it if Androfill is available locally?

Depends on your priorities. If you want a permanent result and Androfill is your only local option, PMMA in Mexico may be worth the travel — see our Tijuana traveling patient guide. If you prefer temporary and reversible, Androfill locally is a valid choice.

Clinical Takeaways

  • Androfill is HA-based. PMMA is permanent. Neither is universally superior.

  • Reversibility is a clinical feature, not a default virtue.

  • The 10-year cost comparison is meaningfully different from the per-session cost comparison.

  • Provider experience matters more than material choice for both safety and outcome.

  • A consultation that presents only one option regardless of the patient in front of it is not a consultation.

Bibliography

  1. Casavantes, L., Lemperle, G., Morales, P. "Penile Girth Enhancement with PMMA-Based Soft Tissue Fillers." J Sex Med 13, no. 9 (2016): 1414–1422.

  2. Manfredi, C., et al. "Penile Enhancement: A Comprehensive and Current Perspective." Current Urology (2024). PMC12076428.

  3. Pang, K.H., et al. "Complications and Outcomes Following Injection of Foreign Material into the Male External Genitalia." Int J Impot Res (2023).